Search
ORM-12741
go.drugbank.com/drugs/DB12057InvestigationalORM-12741 has been used in trials studying the basic science and treatment of Alzheimer's Disease.
ORG-25935
go.drugbank.com/drugs/DB12220InvestigationalOrg 25935 has been used in trials studying the treatment of Alcoholism, Schizophrenia, and Panic Disorder.
Brilanestrant
go.drugbank.com/drugs/DB12253InvestigationalARN-810 has been used in trials studying the basic science and treatment of Breast Cancer.
CRS-3123
go.drugbank.com/drugs/DB12262InvestigationalCRS3123 has been used in trials studying the treatment of Clostridial Infection and Clostridium Difficile Colitis.
Dexelvucitabine
go.drugbank.com/drugs/DB12470InvestigationalDexelvucitabine has been used in trials studying the treatment of HIV Infections and Human Immunodeficiency Virus.
PD-217014
go.drugbank.com/drugs/DB12493InvestigationalPD-217,014 has been used in trials studying the treatment of Pain and Irritable Bowel Syndrome.
Seletalisib
go.drugbank.com/drugs/DB12706InvestigationalSeletalisib has been used in trials studying the treatment and basic science of Primary Sjogren's Syndrome.
LCP-AtorFen
go.drugbank.com/drugs/DB05769InvestigationalLCP-AtorFen is a fixed-dose combination therapy for the treatment of high cholesterol levels combining atorvastatin (the active ingredient of Lipitor®) and the lowest dose of fenofibrate without food effect. LCP-AtorFen is designed to be...
CVT-6883
go.drugbank.com/drugs/DB05936ExperimentalCVT-6883 is a selective, potent and orally available A2B-adenosine receptor antagonist which CV Therapeutics is investigating for the potential treatment of asthma and other conditions related to inflammation and fibrosis.